We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neuroptis Biotech Announces the Preclinical Results for its Dry Eye Product ML7

News   Nov 13, 2013

 
Neuroptis Biotech Announces the Preclinical Results for its Dry Eye Product ML7
 
 
 

RELATED ARTICLES

Discovering the Parameters That Govern the Encapsulation of Drugs

News

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Fast-acting Psychedelic Eases Depression and Anxiety

News

Researchers have discovered that use of the synthetic psychedelic, 5-methocy-N,-N-dimethyltryptamine, appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE